These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28211476)

  • 1. Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events.
    Crawford Parks TE; Marcellus KA; Langill J; Ravel-Chapuis A; Michaud J; Cowan KN; Côté J; Jasmin BJ
    Sci Rep; 2017 Feb; 7():42342. PubMed ID: 28211476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines".
    Sanna L; Piredda R; Marchesi I; Bordoni V; Forcales SV; Calvisi DF; Bagella L
    Chem Biol Interact; 2019 Oct; 312():108813. PubMed ID: 31494105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
    Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
    Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles for the RNA-binding protein Staufen1 in prostate cancer.
    Marcellus KA; Crawford Parks TE; Almasi S; Jasmin BJ
    BMC Cancer; 2021 Feb; 21(1):120. PubMed ID: 33541283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples.
    Toffolatti L; Frascella E; Ninfo V; Gambini C; Forni M; Carli M; Rosolen A
    J Pathol; 2002 Apr; 196(4):450-8. PubMed ID: 11920742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of autophagy by STAU1 in alveolar rhabdomyosarcoma and non-transformed skeletal muscle cells.
    Almasi S; Crawford Parks TE; Ravel-Chapuis A; MacKenzie A; Côté J; Cowan KN; Jasmin BJ
    Cell Oncol (Dordr); 2021 Aug; 44(4):851-870. PubMed ID: 33899158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.
    De Salvo M; Raimondi L; Vella S; Adesso L; Ciarapica R; Verginelli F; Pannuti A; Citti A; Boldrini R; Milano GM; Cacchione A; Ferrari A; Collini P; Rosolen A; Bisogno G; Alaggio R; Inserra A; Locatelli M; Stifani S; Screpanti I; Miele L; Locatelli F; Rota R
    PLoS One; 2014; 9(5):e96238. PubMed ID: 24797362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staufen1 controls mitochondrial metabolism via HIF2α in embryonal rhabdomyosarcoma and promotes tumorigenesis.
    Almasi S; SarmastiEmami S; Baird S; Ning Z; Figeys D; Côté J; Cowan KN; Jasmin BJ
    Cell Mol Life Sci; 2023 Oct; 80(11):328. PubMed ID: 37847286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.
    Srivastava RK; Kaylani SZ; Edrees N; Li C; Talwelkar SS; Xu J; Palle K; Pressey JG; Athar M
    Oncotarget; 2014 Dec; 5(23):12151-65. PubMed ID: 25432075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
    Kouraklis G; Triche TJ; Wesley R; Tsokos M
    Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
    Belyea BC; Naini S; Bentley RC; Linardic CM
    Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas.
    Mahoney SE; Yao Z; Keyes CC; Tapscott SJ; Diede SJ
    Epigenetics; 2012 Apr; 7(4):400-8. PubMed ID: 22419069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myb regulates tumorigenic potential of embryonal rhabdomyosarcoma cells.
    Kaspar P; Prochazka J; Efenberkova M; Juhasz A; Novosadova V; Sedlacek R
    Sci Rep; 2019 Apr; 9(1):6342. PubMed ID: 31004084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.
    Annavarapu SR; Cialfi S; Dominici C; Kokai GK; Uccini S; Ceccarelli S; McDowell HP; Helliwell TR
    Lab Invest; 2013 Oct; 93(10):1090-9. PubMed ID: 23999248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.
    Saini M; Verma A; Mathew SJ
    Cell Death Dis; 2018 Feb; 9(2):237. PubMed ID: 29445192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RNA-binding protein Staufen1 impairs myogenic differentiation via a c-myc-dependent mechanism.
    Ravel-Chapuis A; Crawford TE; Blais-Crépeau ML; Bélanger G; Richer CT; Jasmin BJ
    Mol Biol Cell; 2014 Nov; 25(23):3765-78. PubMed ID: 25208565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target.
    Mercado GE; Xia SJ; Zhang C; Ahn EH; Gustafson DM; Laé M; Ladanyi M; Barr FG
    Genes Chromosomes Cancer; 2008 Jun; 47(6):510-20. PubMed ID: 18335505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.
    Sugito N; Taniguchi K; Kuranaga Y; Ohishi M; Soga T; Ito Y; Miyachi M; Kikuchi K; Hosoi H; Akao Y
    Nucleic Acid Ther; 2017 Dec; 27(6):365-377. PubMed ID: 28981396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.